...
首页> 外文期刊>Medicine. >Extracorporeal membrane oxygenation treatment of a H7N9-caused respiratory failure patient with mechanical valves replacement history: A case report
【24h】

Extracorporeal membrane oxygenation treatment of a H7N9-caused respiratory failure patient with mechanical valves replacement history: A case report

机译:H7N9引起呼吸衰竭并机械瓣膜置换史的体外膜氧合作用治疗:病例报告

获取原文
获取原文并翻译 | 示例

摘要

Background:Patients with respiratory failure caused by H7N9 may benefit from veno-venous, veno-arterial, and veno-veno-arterial extracorporeal membrane oxygenation (ECMO) support.Case summary:A 55-year-old male patient was suffering from H7N9-caused acute respiratory distress syndrome (ARDS). He had a mechanical mitral and aortic valve replacement surgery and was using warfarin for anticoagulation. After prolonged mechanical ventilation, oxygen saturation was not improved. Veno-veno ECMO was then applied. After 16 days of extracorporeal life support, the patient successfully weaned from ECMO, with relatively good pulmonary recovery.Conclusion:This report demonstrates that ECMO support can help treating life-threatening diseases such as H7N9-associated ARDS. Because of his special mitral and aortic valve replacement surgery history and long duration of mechanical ventilation before ECMO, we report it as a separate case, hoping to provide some reference for ECMO treatment.
机译:背景:由H7N9引起的呼吸衰竭的患者可能会受益于静脉,静脉和动脉-静脉的体外膜氧合(ECMO)支持。病例摘要:一名55岁的男性患者患有H7N9-引起急性呼吸窘迫综合征(ARDS)。他进行了机械性二尖瓣和主动脉瓣置换手术,并正在使用华法林进行抗凝治疗。长时间机械通气后,氧饱和度未改善。然后应用Veno-Veno ECMO。经过16天的体外生命支持,该患者成功从ECMO断奶,肺恢复良好。由于他有特殊的二尖瓣和主动脉瓣置换手术史,并且在进行ECMO之前需要长期进行机械通气,因此我们将其单独报告,希望为ECMO治疗提供一些参考。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号